Lynch syndrome accounts for 2–5% of all colorectal cancer (CRC) cases, but approximately 15% of sporadic CRC patients also show somatic inactivation of MMR, mostly due to hypermethylation of the MLH1 promoter (2). The gene discussed is MLH1; the disease is Lynch syndrome.